凝血酶原时间

凝血酶原时间延长早产儿体内的维生素K水平

Vitamin K status of preterm infants with a prolonged prothrombin time

采用Quick法测定大鼠凝血酶原时间。

Prothrombin time was determined by quick method .

围体外循环手术期凝血因子X和凝血酶原时间检测的价值

The value of measurement of Factor X and PT in cases with peri-operation of extracorporeal circulation

SPF级封闭群SD大鼠血清生化值及凝血酶原时间值的测定

Serum Biochemical and Prothrombin Reference Rangers of SPF Closed Colony SD Rat

目的分析影响凝血酶原时间国际标准化比值（internationalnormalizedratio，INR）一致性的因素。

Objective To investigate the factors that influence the consistency of international normalized ratio ( INR ) of prothrombin time .

使用EDTA抗凝血检测凝血酶原时间

Use of EDTA Samples for Prothrombin time Measurement

必须定期检查凝血酶原时间（PT），或做其他相应的凝血试验来控制剂量。

Dosage should be controlled by periodic determinations of prothrombin time ( PT ) or other suitable coagulation tests .

对80例次围体外循环手术患者动态检测凝血因于X（FX）和凝血酶原时间（PT）。

Factor X and PT were dynamically measured 80 times in 16 cases with peri-operation of extracorporeal circulation .

目的探讨中晚期肝病患者凝血酶原时间（PT）的标准化形式。

Objective To determine which expression mode of prothrombin time ( PT ) might achieve PT standardization in patients with advanced liver diseases .

目的探讨布加氏综合征（Budd-Chiarisyndrome，BCS）患者血浆凝血酶原时间（PT）的变化情况。

Objective To investigate the changes of prothrombin time ( PT ) in patients with Budd-Chiari Syndrome ( BCS ) .

术后根据凝血酶原时间（PT），使用普通肝素或低分子肝素预防性抗凝。

Regular heparin or low-molecular-weight heparin as a prophylactic anticoagulation therapy was maintained during and after ( operation ) as indicated by prothrombin time .

减轻静脉血栓的湿重、干重（p＜0.05，p＜0.01），延长凝血酶原时间和部分凝血活酶时间（p＜0.05，p＜0.01）；

Could reduce the wet and dry weight of vein thrombus ( p < 0.05 , p < 0.01 ) and prolong the prothrombin time and partial thromboplastin time ( p < 0.05 , p < 0.01 );

生化检查结果发现当血硒浓度上升到1μg/ml（硒日摄入量850μg）时，凝血酶原时间延长的病例显著上升；

Biochemical parameters indicate that cases of delay blood prothrombin time distinctly increases as blood-Se level increases to beyond 1 μ g / ml ( daily Se intake 850 μ g ) .

防风有效部位中剂量和大剂量能延长凝血酶原时间和抑制由ADP诱导的血小板聚集。

Prothrombin time was prolonged and ADP-induced platelet aggregation was inhibited in middle and high dose group .

总胆红素、凝血酶原时间变化亦优于对照组（P＜0.05），但丙氨酸转氨酶治疗后2组间无明显差别（P＞0.05）。

The changes of serum bilirubin and prothrombin time in treatment group were superior to that in control group ( P0.05 ), but there was not significant difference of ALT change between treatment group and control group ( P0.05 ) .

方法：凝固法测凝血酶原时间（PT），活化的部分凝血活酶时间（APTT），凝血酶时间。

Methods : coagulate determined prothrombin time ( PT ), activated partial thromboplastin time ( APTT ) and thrombin time ( TT ) .

两组患儿输液后凝血酶原时间（PT）均显著延长（P<0·01），但均在正常范围。

The erythrocyte electrophoresis index was obviously higher ( P < 0.05 ), and prothrombin time was longer than that before in two groups ( P < 0.01 ) .

采用大剂量腹腔注射LPS复制大鼠败血症模型，观察和对比各组大鼠的临床表现、血小板聚集性和凝血酶原时间（PT）。

Septicaemia model was induced by celiac injection of large dose LPS . We observed and compared clinical manifestations , prothrombin time ( PT ) and platelet aggregation .

给药8周后处死大鼠，测定体质量、肾质量／体质量（R／B）、凝血酶原时间（PT），并观察肾小球形态学改变。

Rats were killed after 8 weeks of treatment , their body mass , ratio of renal mass and body mass and prothrombin time ( PT ) were measured and renal morphological alterations were observed .

各用药组大鼠的凝血酶原时间均较模型组大鼠延长（P<0.01），以阿司匹林组、尼莫低平组、大黄苷元51.84mg/（kg·d），25.92mg/（kg·d）组的延长明显；

The prothrombin time in treated groups was longer than that in model group ( P < 0.01 ), which was prolonged obviously in aspirin , Nimodipine and low dosage of rhubarb aglycone groups .

肝硬化患者血浆凝血酶原时间和血清肝纤维化指标与Child-Pugh分级的关系

Relationship of Child-Pugh class with plasma prothrombin time and serum liver fibrosis indexes in patients with cirrhosis

测定颈总动脉血栓形成后的大鼠全血凝固时间（CT）、血浆凝血酶原时间（PT）和活化部分凝血活酶时间（APTT），观察海带胞壁多糖对血液凝固的影响。

Blood coagulation time ( CT ), plasma prothrombin time ( PT ) and partial thromboplastin time ( APTT ) were measured to observe the effect of CWP on blood coagulation .

透析时取血检测部分凝血活酶时间（aPTT）、凝血酶原时间（PT）、凝血酶时间（TT）及因子Xa活性；

Active partial thromboplastin time ( aPTT ), prothrombin time ( PT ), thrombin time ( TT ) and factor Xa activity were determined during dialysis .

凝血酶原时间：治疗组与对照组比较，治疗1月、3月时PT基本正常者，两者之间差异没有显著性（P0.05）。

Prothrombin time : The treatment group compared with the control group , treatment in March when the PT is normal persons , there was no significant difference between sex ( P 0.05 ) .

方法选择出生～6个月婴儿临床出血病例，维生素K治疗前后检测凝血酶原时间、部分凝血活酶时间及凝血酶原前体蛋白（PIVKA-Ⅱ）进行判断。

Methods To choose the infants under 6 months with clinical hemorrhage to judge the monitoring prothrombin time , the partial thromboplastin time and the specific target PIVKA - ⅱ of lacked vitamin K around the treatment with vitamin K.

目的探讨不同的抗凝血体外贮存条件对凝血酶原时间（PT）、活化部分凝血活酶时间（APTT）的影响。

Objective To investigate the effects of different storage temperatures on anticoagulated blood hemagglutination tests , including prothrombin time ( PT ), and activated partial thromboplastin time ( APTT ) .

结论凝血活酶试剂敏感度指数（ISI）值标定的不准确性和INR计算不正确的是引起广东省临床实验室间凝血酶原时间测定变异大的主要原因。

Conclusions The inaccuracy in determination of ISI and the incorrect calculations of INR are the main reasons for the interlaboratory variation in Guangdong province .

发现怀牛膝多糖ABP能延长小鼠凝血时间（CT）、大鼠血浆凝血酶原时间（PT）、白陶土部分凝血活酶时间（KPTT）。

We found ABP prolonged coagulation time ( CT ) in mice , increased plasma prothrombin time ( PT ) and kaolin partial thromboplastin time ( KPTT ) in rats .

目的探讨临床口服抗凝治疗时血浆凝血酶原时间（PT）监测的标准化，为临床提供比较准确的PT国际标准化比值（PTINR）结果。

Objective To investigate the standardization on the prothrombin time-international normalized ratio ( PT-INR ) determination , it will be great help to provide more accurate testing results on clinical anti-coagulation therapy .

方法用活化部分凝血活酶时间（APTT）、凝血酶原时间（PT）及FX促凝活性（FX：C）测定进行表型诊断；

Methods The activated partial thromboplastin time ( APTT ), prothrombin time ( PT ) and FX ac-tivity ( FX : C ) test were adopted for phenotype diagnosis .